NASDAQ:NRXS NeurAxis (NRXS) Stock Price, News & Analysis → AI's Next Magnificent Seven (From The Oxford Club) (Ad) Free NRXS Stock Alerts $2.92 -0.07 (-2.34%) (As of 06/10/2024 ET) Add Compare Share Share Today's Range$2.92▼$3.1950-Day Range$2.76▼$3.4552-Week Range$1.80▼$6.93Volume9,511 shsAverage Volume10,866 shsMarket Capitalization$19.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Get NeurAxis alerts: Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About NeurAxis Stock (NASDAQ:NRXS)NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.Read More NRXS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRXS Stock News HeadlinesJune 7 at 9:00 AM | globenewswire.comNeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit DisclosureJune 5, 2024 | americanbankingnews.comNeurAxis (NASDAQ:NRXS) & Outset Medical (NASDAQ:OM) Head to Head ContrastMay 24, 2024 | msn.comNeurAxis, Inc. (NASDAQ:NRXS) Q1 2024 Earnings Call TranscriptMay 22, 2024 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Reports First Quarter 2024 Financial ResultsMay 22, 2024 | msn.comNeurAxis GAAP EPS of -$0.32, revenue of $0.65MMay 22, 2024 | globenewswire.comNeurAxis Reports First Quarter 2024 Financial ResultsMay 21, 2024 | globenewswire.comNeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 16, 2024 | finance.yahoo.comNeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in FloridaMay 15, 2024 | globenewswire.comNeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024April 23, 2024 | globenewswire.comNeurAxis Announces New Medical Policy Coverage in North DakotaApril 12, 2024 | finance.yahoo.comNeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call TranscriptApril 11, 2024 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 11, 2024 | seekingalpha.comNeurAxis, Inc. (NRXS) Q4 2023 Earnings Call TranscriptApril 9, 2024 | globenewswire.comNeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 1, 2024 | globenewswire.comNeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024March 27, 2024 | globenewswire.comNeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center RegistryMarch 11, 2024 | globenewswire.comNeurAxis Announces Highmark BCBS Policy CoverageMarch 4, 2024 | globenewswire.comNeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy CoverageFebruary 27, 2024 | globenewswire.comNeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceFebruary 1, 2024 | au.finance.yahoo.comNeurAxis, Inc. (NRXS)January 31, 2024 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Appoints Timothy Henrichs as Chief Financial OfficerJanuary 31, 2024 | finance.yahoo.comNeurAxis Appoints Timothy Henrichs as Chief Financial OfficerDecember 20, 2023 | finanznachrichten.deNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerDecember 20, 2023 | finance.yahoo.comNeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerNovember 21, 2023 | finanznachrichten.deNeurAxis, Inc.: NeurAxis Reports Third Quarter 2023 Financial ResultsSee More Headlines Receive NRXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/20/2024Today6/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:NRXS CUSIPN/A CIK1933567 Webneuraxis.com Phone(812) 689-0791FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.73) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,630,000.00 Net Margins-633.10% Pretax Margin-633.15% Return on EquityN/A Return on Assets-926.02% Debt Debt-to-Equity RatioN/A Current Ratio0.11 Quick Ratio0.10 Sales & Book Value Annual Sales$2.46 million Price / Sales7.89 Cash FlowN/A Price / Cash FlowN/A Book Value($0.27) per share Price / Book-10.81Miscellaneous Outstanding Shares6,650,000Free FloatN/AMarket Cap$19.42 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Brian Carrico (Age 42)President, CEO & Director Comp: $839.4kMr. Timothy Robert Henrichs (Age 51)Chief Financial Officer Comp: $23.84kDr. Adrian Miranda (Age 54)Senior VP of Science & Technology and Chief Medical Officer Comp: $323.05kDr. Thomas Carrico (Age 67)Chief Regulatory Officer and Compliance Officer & Privacy Officer Comp: $411.1kDr. Christopher Robin Brown D.D.S. (Age 70)Founder, Director of Innovation & Director Key CompetitorsHyperfineNASDAQ:HYPRelectroCoreNASDAQ:ECORCuteraNASDAQ:CUTRPrecision OpticsNASDAQ:POCIIRIDEXNASDAQ:IRIXView All Competitors NRXS Stock Analysis - Frequently Asked Questions Should I buy or sell NeurAxis stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NeurAxis in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NRXS shares. View NRXS analyst ratings or view top-rated stocks. How have NRXS shares performed in 2024? NeurAxis' stock was trading at $2.67 at the beginning of 2024. Since then, NRXS shares have increased by 9.4% and is now trading at $2.92. View the best growth stocks for 2024 here. How were NeurAxis' earnings last quarter? NeurAxis, Inc. (NASDAQ:NRXS) posted its quarterly earnings data on Monday, May, 20th. The company reported ($0.32) earnings per share for the quarter. The business had revenue of $0.65 million for the quarter. When did NeurAxis IPO? NeurAxis (NRXS) raised $7 million in an IPO on Wednesday, August 9th 2023. The company issued 1,098,667 shares at a price of $6.00 per share. How do I buy shares of NeurAxis? Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NRXS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.